ASPI.NASDAQAsp Isotopes INC

SCHEDULE 13G: Paul E. Mann Discloses 14.2% Stake in ASP Isotopes Inc.

Sentiment:

Beneficial Ownership Report


Paul E. Mann has reported a beneficial ownership of 14.2% of ASP Isotopes Inc.'s common stock as of December 31, 2022, including shares held directly and exercisable warrants.

Summary

  • Paul E. Mann has filed a Schedule 13G with the SEC, disclosing his beneficial ownership in ASP Isotopes Inc.
  • As of December 31, 2022, Mr. Mann beneficially owns a total of 5,309,722 shares of ASP Isotopes Inc. common stock.
  • This ownership stake represents 14.2% of the company's total outstanding common stock.
  • The calculation of the percentage is based on 35,907,127 outstanding shares of ASP Isotopes Inc. as of December 31, 2022.
  • The beneficially owned shares comprise 5,087,500 shares held directly by Paul Mann and an additional 222,222 shares issuable upon the exercise of warrants exercisable within 60 days of December 31, 2022.
  • Mr. Mann holds sole voting power and sole dispositive power over all 5,309,722 beneficially owned shares.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing is a factual disclosure of ownership. The presence of a significant individual stake (14.2%) can be interpreted as a positive signal of investor confidence, but the document provides no other operational or financial details to assess overall sentiment.

Positives

  • A significant individual investor, Paul E. Mann, holds a substantial 14.2% stake in ASP Isotopes Inc., which could signal confidence in the company's long-term prospects.
  • The inclusion of shares issuable from warrants suggests a strategic or long-term investment perspective from the reporting person.

Future Outlook

The document is a beneficial ownership report and does not contain forward-looking statements or guidance from the company or the reporting person regarding the company's future performance or strategic direction.

Industry Context

This filing is a standard disclosure of a significant ownership stake by an individual investor in a publicly traded company. It does not provide specific industry context or trends beyond identifying ASP Isotopes Inc. as the issuer, which operates in a sector related to isotopes.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a significant individual shareholder's stake, which may be viewed positively as a sign of conviction in the company's value.

Key Dates

DateDescription
12/31/2022Date of the event which required the filing of this statement, reflecting the beneficial ownership position.
02/14/2025Date the Schedule 13G filing was signed by Paul E. Mann.

Keywords

ASP Isotopes Inc., Paul E. Mann, Schedule 13G, Beneficial Ownership, Common Stock, Shareholder, Warrants, SEC Filing, Ownership Disclosure, Isotopes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.